GF
BVS icon

Gabelli Funds’s Bioventus BVS Stock Holding History

Gabelli Funds’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$52.7K – 1114
2023
Q4 		$52.7K Sell
10,000
-8,000
-44% -$31.7K ﹤0.01% 1046
2023
Q3 		$59.4K Sell
18,000
-5,200
-22% -$18.2K ﹤0.01% 1054
2023
Q2 		$67K Hold
23,200
– – ﹤0.01% 1057
2023
Q1 		$24.8K Sell
23,200
-1,600
-6% -$3.06K ﹤0.01% 1090
2022
Q4 		$64.7K Sell
24,800
-1,000
-4% -$4.37K ﹤0.01% 1120
2022
Q3 		$181K Hold
25,800
– – ﹤0.01% 1167
2022
Q2 		$176K Buy
25,800
+600
+2% +$6.12K ﹤0.01% 1199
2022
Q1 		$355K Sell
25,200
-1,230
-5% -$16.5K ﹤0.01% 1129
2021
Q4 		$383K Buy
+26,430
New +$376K ﹤0.01% 1132

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Gabelli Funds's BVS Position: Q1 2024 in Review

Gabelli Funds sold out of Bioventus (BVS) in Q1 2024, closing a stake of 10,000 shares — an estimated $52.7K sold.

Gabelli Funds first reported a position in BVS in Q4 2021 and held it in 9 quarters. The position peaked at $383K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • Gabelli Funds reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
  • Gabelli Funds sold 10,000 Bioventus shares in Q1 2024, an estimated $52.7K.
  • Gabelli Funds first reported a position in Bioventus in Q4 2021 and held it in 9 quarters.
  • Gabelli Funds's Bioventus position peaked at $383K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Gabelli Funds's 13F filing for Q1 2024, filed 14 May 2024.